Key result
Bevacizumab resolves malignant pericardial and pleural effusion in ovarian clear cell carcinoma.
Why the study?
Does bevacizumab resolve malignant pericardial and pleural effusion in patients with ovarian clear cell carcinoma?
Does bevacizumab resolve malignant pericardial and pleural effusion in patients with ovarian clear cell carcinoma?
Bevacizumab may be an effective treatment for malignant pericardial and pleural effusion associated with ovarian clear cell carcinoma.
May support bevacizumab for malignant effusions in ovarian clear cell carcinoma; single-case observation leaves open prospective validation.
•An ovarian clear cell carcinoma patient showed malignant pericardial and pleural effusion.•She subsequently experienced pulmonary embolism due to cancer progression.•Pericardial and pleural effusion were successfully treated using bevacizumab.
No takes yet. Share an insight, caveat, or question.
Ueda et al. (2016) studied this question. Bevacizumab successfully resolved malignant pericardial and pleural effusion associated with ovarian clear cell carcinoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: